ArticleDiscover nano2026
Mechanistic evaluation of antibacterial and photocatalytic properties of biosynthesized silver nanoparticles against pathogenic bacteria and synthetic dyes.
Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hazardous materials and bacteria are known to cause life-threatening issues to people with compromised immune systems. Another global threat of manufacturing industries; synthetic dyes are one of the key factors of water pollution; it is difficult to treat this wastewater in an efficient and economical way. Thus, there is an urgent need for developing new antibacterial and photocatalytic agents to combat harmful microorganisms and biohazardous compounds (dyes). Therefore, in present research work, biosynthesized silver nanoparticles (AgNPs) were evaluated as a novel antibacterial and photocatalytic agent. The cyanobacterium (Anabaena variabilis) cell-free extract was used to synthesis AgNPs by following the optimized conditions, which included a 1:9 cell extract to 1 mM AgNO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.